Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (693)
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
1,700
Price
$25.29
Total Value
$42.99K
Shares Held After
377,802
% of Holdings
0.4%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
10,181
Price
$24.38
Total Value
$248.21K
Shares Held After
379,502
% of Holdings
2.6%
Grace Therapeutics, Inc. (GRCE)
Opaleye Management Inc. — 10% Owner
Shares
21,390
Price
$1.93
Total Value
$41.19K
Shares Held After
2,970,000
% of Holdings
0.7%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
5,800
Price
$2.40
Total Value
$13.92K
Shares Held After
2,995,909
% of Holdings
0.2%
Acrivon Therapeutics, Inc. (ACRV)
Miller Mary — Chief Legal Officer
Shares
513
Price
$1.84
Total Value
$943.92
Shares Held After
81,202
% of Holdings
0.6%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
100,000
Price
$8.19
Total Value
$818.52K
Shares Held After
1,137,000
% of Holdings
8.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$590.40
Total Value
$94.46K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$589.50
Total Value
$141.48K
Shares Held After
324,603
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
783
Price
$588.19
Total Value
$460.55K
Shares Held After
324,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
937
Price
$587.24
Total Value
$550.24K
Shares Held After
325,626
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,280
Price
$586.31
Total Value
$750.47K
Shares Held After
326,563
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,756
Price
$585.24
Total Value
$1.03M
Shares Held After
327,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,200
Price
$584.21
Total Value
$701.06K
Shares Held After
329,599
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
760
Price
$583.09
Total Value
$443.15K
Shares Held After
330,799
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$581.83
Total Value
$232.73K
Shares Held After
331,559
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$581.03
Total Value
$209.17K
Shares Held After
331,959
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$579.69
Total Value
$92.75K
Shares Held After
332,319
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$578.59
Total Value
$92.57K
Shares Held After
332,479
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$577.28
Total Value
$161.64K
Shares Held After
332,639
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
190
Price
$576.80
Total Value
$109.59K
Shares Held After
332,919
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
130
Price
$575.32
Total Value
$74.79K
Shares Held After
333,109
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$573.39
Total Value
$22.94K
Shares Held After
333,239
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$571.76
Total Value
$91.48K
Shares Held After
333,279
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$570.08
Total Value
$91.21K
Shares Held After
333,439
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$565.09
Total Value
$90.41K
Shares Held After
333,599
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
110
Price
$563.98
Total Value
$62.04K
Shares Held After
333,759
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
74
Price
$562.97
Total Value
$41.66K
Shares Held After
333,869
% of Holdings
0.0%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
500
Price
$37.52
Total Value
$18.76K
Shares Held After
54,645
% of Holdings
0.9%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
31,250
Price
$0.16
Total Value
$5.09K
Shares Held After
158,072
% of Holdings
19.8%
Anixa Biosciences Inc (ANIX)
KUMAR AMIT — Director
Shares
8,000
Price
$2.72
Total Value
$21.76K
Shares Held After
680,000
% of Holdings
1.2%
Rapport Therapeutics, Inc. (RAPP)
PAUL STEVEN M — Director
Shares
35,714
Price
$27.28
Total Value
$974.28K
Shares Held After
77,380
% of Holdings
46.2%
Rapport Therapeutics, Inc. (RAPP)
MARAGANORE JOHN — Director
Shares
1,172
Price
$26.92
Total Value
$31.55K
Shares Held After
9,411
% of Holdings
12.5%
Rapport Therapeutics, Inc. (RAPP)
MARAGANORE JOHN — Director
Shares
8,239
Price
$26.38
Total Value
$217.34K
Shares Held After
8,239
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Silva Paul M — Director
Shares
3,680
Price
$27.07
Total Value
$99.64K
Shares Held After
3,680
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Young Wendy B. — Director
Shares
3,789
Price
$26.39
Total Value
$99.99K
Shares Held After
13,289
% of Holdings
28.5%
Allogene Therapeutics, Inc. (ALLO)
Parker Geoffrey M. — CHIEF FINANCIAL OFFICER
Shares
36,342
Price
$1.34
Total Value
$48.70K
Shares Held After
1,045,877
% of Holdings
3.4%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
2,595
Price
$28.94
Total Value
$75.10K
Shares Held After
198,937
% of Holdings
1.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
100
Price
$94.91
Total Value
$9.49K
Shares Held After
211,930
% of Holdings
0.0%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
2,000
Price
$93.71
Total Value
$187.42K
Shares Held After
212,030
% of Holdings
0.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
2,000
Price
$92.66
Total Value
$185.32K
Shares Held After
214,030
% of Holdings
0.9%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
2,985
Price
$91.76
Total Value
$273.90K
Shares Held After
216,030
% of Holdings
1.4%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
5,101
Price
$90.98
Total Value
$464.09K
Shares Held After
219,015
% of Holdings
2.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
7,623
Price
$89.74
Total Value
$684.09K
Shares Held After
224,116
% of Holdings
3.3%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
1,677
Price
$89.20
Total Value
$149.59K
Shares Held After
231,739
% of Holdings
0.7%
Kodiak Sciences Inc. (KOD)
BORGESON JOHN A. — Chief Financial Officer
Shares
8,514
Price
$87.67
Total Value
$746.42K
Shares Held After
233,416
% of Holdings
3.5%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,210
Price
$29.16
Total Value
$64.45K
Shares Held After
450,035
% of Holdings
0.5%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
607
Price
$126.19
Total Value
$76.60K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,663
Price
$125.16
Total Value
$208.15K
Shares Held After
607
% of Holdings
73.3%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
2,043
Price
$123.62
Total Value
$252.56K
Shares Held After
2,270
% of Holdings
47.4%
AGIOS PHARMACEUTICALS, INC. (AGIO)
Gheuens Sarah — Chief Medical Officer
Shares
1,489
Price
$37.53
Total Value
$55.88K
Shares Held After
54,645
% of Holdings
2.7%
693 transactions